newsfilter
← Latest News
Bloomberg·

Merck to Buy Autoimmune Drug Developer Pandion for $1.85 Billion

Merck & Co. agreed to acquire Pandion Therapeutics Inc., a biotechnology company developing therapies for autoimmune diseases, for $1.85 billion.